Abstract
Despite appropriate surgical therapy, 5–10 % of patients with chronic rhinosinusitis (CRS) and nasal polyps (NP) experience disease recurrences. It has been suggested that angiogenesis may relate to the pathogenesis and prognosis of CRS with NP. Endoglin (CD105) is a component of the receptor complex of transforming growth factor-beta, a pleiotropic cytokine that modulates angiogenesis. A series of patients treated surgically for CRS with NP was analyzed to assess the relationship between CD105 expression, main clinicopathological features, and recurrence rate. The immunohistochemical expression of CD105 was assessed in 70 patients consecutively operated for CRS with NP. In the univariate setting, the presence of CD105 (1/0) showed a trend towards a significant association with increasing NP dimensions (p = 0.054). Intensity of CD105 reaction was also significantly associated with NP size (0.04) and with an eosinophilic histology (p = 0.048). In our multivariate setting, only asthma (p = 0.016), hypereosinophilia (p = 0.022), and preoperative polyposis score (p = 0.046) retained their independent prognostic significance in relation to NP recurrence. Further efforts are needed to elucidate the biological, angiogenic and proliferative mechanisms behind recurrent NP. Our preliminary results support the clinical utility of extra postoperative care, in terms of closer follow-ups and medication with oral anti-histamines, topical and/or oral steroids, and antileukotrienes in patients with asthma, advanced nasal polyposis at presentation, and serum hypereosinophilia.
Similar content being viewed by others
References
Kennedy DW (2004) Pathogenesis of chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 193:6–9
Jani AL, Hamilos DL (2005) Current thinking on the relationship between rhinosinusitis and asthma. J Asthma 42:1–7
Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28:717–722
Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW (2011) Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 120:162–166
Krouse JH, Veling MC, Ryan MW, Pillsbury HC 3rd, Krouse HJ, Joe S, Heller AJ, Han JK, Fineman SM, Brown RW (2007) Executive summary: asthma and the unified airway. Otolaryngol Head Neck Surg 136:699–706
Proimos E, Papadakis CE, Chimona TS, Kiagiadaki D, Ferekidis E, Yiotakis J (2010) The effect of functional endoscopic sinus surgery on patients with asthma and CRS with nasal polyps. Rhinology 48:331–338
Karatzanis AD, Samara KD, Antoniou KM, Lymbouridou R, Chatzakis N, Spandidos DA, Velegrakis GA, Siafakas NM (2012) Investigation of angiogenetic pathways in nasal polyposis. Mol Med Rep 5:1158–1162
Hirshoren N, Neuman T, Gross M, Eliashar R (2011) Angiogenesis in chronic rhinosinusitis with nasal polyps and in antrochoanal polyps. Inflamm Res 60:321–327
Watanabe K, Komatsuzaki A (1992) Ultrastructural findings of capillaries in nasal polyps. Rhinology 30:49–56
Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557–6563
Marioni G, D’Alessandro E, Giacomelli L, Staffieri A (2010) CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. J Oral Pathol Med 39:361–367
McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrel J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345–351
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, de Wang Y, Wormald PJ (2012) EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50:1–12
Cappellesso R, Tinazzi A, Giurici T, Simonato F, Guzzardo V, Ventura L, Crescenzi M, Chiarelli S, Fassina A (2014) Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions. Cancer Cytopathol 122:685–693
Hopkins C, Browne JP, Slack R, Lund VJ, Topham J, Reeves BC, Copley LP, Brown P, van der Meulen JH (2006) Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a national audit in England and Wales. Laryngoscope 116:1494–1499
Wittekindt C, Hess A, Bloch W, Sultanie S, Michel O (2002) Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294–298
Marioni G, Gaio E, Giacomelli L, Marchese-Ragona R, Staffieri C, Staffieri A, Marino F (2005) Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma. Acta Otolaryngol 125:307–311
Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, Bousquet J, Chanez P (2001) Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107:73–80
Lin DC, Chandra RK, Tan BK, Zirkle W, Conley DB, Grammer LC, Kern RC, Schleimer RP, Peters AT (2011) Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25:205–208
Bertrand B, Eloy P, Rombeaux P (1997) Allergy and sinusitis. Acta Otorhinolaryngol Belg 51:227–237
Young J, Frenkiel S, Tewfik MA, Mouadeb DA (2007) Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis. Am J Rhinol 21:743–747
Graefe H, Roebke C, Schäfer D, Meyer JE (2012) Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo) 2012:817910
Garcia Cruz ML, Jimenez-Chobillon MA, Teran LM (2012) Rhinosinusitis and aspirin-exacerbated respiratory disease. J Allergy (Cairo) 2012:273752
Ikeda K, Shiozawa A, Ono N, Kusunoki T, Hirotsu M, Homma H, Saitoh T, Murata J (2013) Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope 123:E1–9
Payne SC, Borish L, Steinke JW (2011) Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 128:710–720
Malinsky RR, Valera FC, Cavallari FE, Küpper DS, Milaneze C, Silva JS, Tamashiro E, Anselmo-Lima WT (2013) Matrix metalloproteinases and their impact on sinusal extension in chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol 270:1345–1348
Karosi T, Csomor P, Hegyi Z, Sziklai I (2013) The presence of CD209 expressing dendritic cells correlates with biofilm positivity in chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol 270:2455–2463
Acknowledgments
The authors thank Frances Coburn for correcting the English version of this paper. This study was partly supported by Grants No. 60A07-4322/13 (G. Ottaviano) and No. 60A07-1341/12 (G. Marioni) from the University of Padova, Italy.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ottaviano, G., Cappellesso, R., Mylonakis, I. et al. Endoglin (CD105) expression in sinonasal polyposis. Eur Arch Otorhinolaryngol 272, 3367–3373 (2015). https://doi.org/10.1007/s00405-014-3456-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3456-x